TY - JOUR
T1 - 100 A 16-Year Multi-Institutional Study of the Role of Age and EBV Status on PTLD Incidence among Pediatric Heart Transplant Recipients
AU - George, J.F.
AU - Chinnock, Richard E.
AU - Brown, R.N.
AU - Dipchand, A.I.
AU - Webber, S.A.
N1 - We determined the incidence and risk for PTLD among children as a function of age at time of transplant and EBV serology status. Malignancy data were obtained from 3,170 pediatric patients (birth-18yrs) with a median follow-up of 3.85 years at 35 institutions in the Pediatric Heart Transplant Study between 1993 and 2009.
PY - 2011/4/1
Y1 - 2011/4/1
N2 - Purpose: We determined the incidence and risk for PTLD among children as a function of age at time of transplant and EBV serology status. Methods and Materials: Malignancy data were obtained from 3,170 pediatric patients (birth-18yrs) with a median follow-up of 3.85 years at 35 institutions in the Pediatric Heart Transplant Study between 1993 and 2009. PTLD and EBV status were analyzed as a function of transplant year, transplant age, and demographic variables. (Figure Presented) Results: Of 151 malignancy events, 147 (97%) were PTLD. Actuarial freedom from PTLD was lowest among patients From birth to 10 years of age, with the peak hazard for PTLD at one year post-transplantation occurring in patients 5.45 years old at transplant, (left panel). Among recipients of EBV+ donor hearts, EBV-recipients exhibited an increased risk of PTLD (p
AB - Purpose: We determined the incidence and risk for PTLD among children as a function of age at time of transplant and EBV serology status. Methods and Materials: Malignancy data were obtained from 3,170 pediatric patients (birth-18yrs) with a median follow-up of 3.85 years at 35 institutions in the Pediatric Heart Transplant Study between 1993 and 2009. PTLD and EBV status were analyzed as a function of transplant year, transplant age, and demographic variables. (Figure Presented) Results: Of 151 malignancy events, 147 (97%) were PTLD. Actuarial freedom from PTLD was lowest among patients From birth to 10 years of age, with the peak hazard for PTLD at one year post-transplantation occurring in patients 5.45 years old at transplant, (left panel). Among recipients of EBV+ donor hearts, EBV-recipients exhibited an increased risk of PTLD (p
UR - https://www.sciencedirect.com/science/article/pii/S1053249811001094
UR - https://www.mendeley.com/catalogue/2f04be6e-b1d1-341b-b2e3-fbfd574b7d5f/
U2 - 10.1016/J.HEALUN.2011.01.107
DO - 10.1016/J.HEALUN.2011.01.107
M3 - Meeting abstract
VL - 30
SP - S41
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 4
ER -